
Masimo Corp: An American healthcare firm innovating non-invasive medical monitoring technology.
Founded in 1989 by Joe Kiani, Masimo Corporation is a pioneering American healthcare firm based in Irvine, California. The company specializes in designing, developing, and licensing innovative medical signal processing and sensor technology for non-invasive monitoring of physiological parameters. Masimo's core mission is to enhance patient care by improving the accuracy and reliability of pulse oximetry and other monitoring technologies. Their product portfolio includes advanced pulse oximeters, baby monitors, and wearable health devices, serving a global market.
Notable figures associated with Masimo include founder and CEO Joe Kiani. The company is publicly traded on Nasdaq under the ticker MASI and is a component of the S&P 400. With a revenue of $2.05 billion in 2023, Masimo has made significant strides in the medical technology industry. Their hospital-proven technologies are trusted by healthcare professionals and athletes alike, contributing to better patient outcomes and advancing the field of non-invasive medical monitoring.

Cercacor Laboratories
cercacor.com

iRhythm
irhythmtech.com

Noninvasive Medical Technologies
nmtinc.org

Cardiox
cardiox.com

AliveCor
alivecor.com

Vital Metrix

Omron Healthcare

ResMed
resmed.com

Raydiant Oximetry

Boston Scientific

Respirix

Noninvasix
noninvasix.com
Edwards Lifesciences
edwards.com

Respiratory Motion

Dexcom
dexcom.com
Companies similar to Masimo include Cercacor Laboratories, iRhythm, Noninvasive Medical Technologies and Cardiox.
Masimo was founded in 1989.
Masimo's headquarters is located in Irvine, CA, US.
Masimo's most recent funding round was for $750M (USD) in August 2022.
As of Aug 15, 2022, Masimo has raised a total of $755M (USD).
Masimo has 1,800 employees as of Feb 6, 2024.